Compare Carparts.Com Inc (PRTS) vs Tango Therapeutics Inc. (TNGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Carparts.Com Inc vs Tango Therapeutics Inc. — how do they compare? Carparts.Com Inc trades at $7.75 (market cap $63.04M), while Tango Therapeutics Inc. trades at $22.5 (market cap $3.74B). The key difference: Tango Therapeutics Inc. is far larger — about 59.3× Carparts.Com Inc's market cap, and Carparts.Com Inc is more actively traded (22,319 versus 3,438,781). Which is the better fit depends on your goals — on Pluang, investors hold Carparts.Com Inc for 45 Days and Tango Therapeutics Inc. for 0 Days on average.
| PRTS | TNGX | |
|---|---|---|
Market Cap | $63.04M | $3.74B |
Volume | 22,319 | 3,438,781 |
Sector | Consumer Cyclical | Health |
52-Week High | $10.00 | $32.90 |
52-Week Low | $3.88 | $7.50 |
Typical Hold Time | 45 Days | 0 Days |
Enterprise Value | $76.01M | $2.76B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CarParts.com (PRTS) trades at $8.11, down 6.46% today, reflecting ongoing volatility amid mixed financials. The company has beaten EPS estimates for three consecutive quarters, yet revenue has declined from $676M in 2023 to $548M in 2025, with net losses widening to -$50M. Analyst sentiment is positive with 60% buy ratings, but negative cash flow from operations and weak profitability metrics highlight operational challenges.
The outlook remains cautious; while low P/S of 0.11 suggests undervaluation, persistent losses and declining revenue pose significant risks. Near-term catalysts depend on reversing negative cash flow and achieving profitability. Investors face upside from execution improvements but downside from competitive pressures and macroeconomic headwinds affecting consumer discretionary spending.
TNGX trades at $22.22, down 8.07% in the last session, reflecting negative investor reaction to recent earnings misses. The stock shows neutral technical signals with key support at $21 and resistance at $23. Fundamentally, the company maintains a high gross margin of 98.25% but faces significant losses with a net income margin of -229.92% and negative cash flow from operations. Recent news highlights institutional buying interest and upcoming clinical trial developments.
Despite strong analyst support with a $45.91 consensus price target (107% upside), TNGX faces substantial execution risks as a clinical-stage biotech. The company's heavy cash burn and lack of profitability require careful monitoring of pipeline progress. Investment appeal hinges on successful drug development outcomes rather than current financial metrics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Carparts.Com Inc
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
Read more on PRTS →About Tango Therapeutics Inc.
Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on precision oncology, developing cancer therapies based on the genetic principle of synthetic lethality, including its PRMT5 inhibitor program.
Read more on TNGX →
